Surgery Partners (SGRY) Common Equity (2014 - 2026)

Surgery Partners has disclosed Common Equity across 13 years of filings, most recently posting $3.1 billion for Q2 2026.

• In Q2 2026, Common Equity fell 1.74% year-over-year to $3.1 billion; the TTM figure through Jun 2026 stood at $3.1 billion (down 1.74% YoY), while the FY2025 annual figure was $3.1 billion, down 2.04% from the prior year.
• Common Equity came in at $3.1 billion for Q2 2026 at Surgery Partners, roughly flat from $3.1 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $3.2 billion in Q4 2024 to a low of $2.0 billion in Q1 2022.
• Average Common Equity over 5 years is $2.9 billion, with a median of $3.1 billion recorded in 2024.
• Year-over-year, Common Equity jumped 82.09% in 2022 and decreased 2.04% in 2025.
• Over 5 years, Common Equity stood at $2.9 billion in 2022, then advanced by 3.18% to $3.0 billion in 2023, then advanced by 5.34% to $3.2 billion in 2024, then decreased by 2.04% to $3.1 billion in 2025, then decreased by 0.95% to $3.1 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $3.1 billion in Q2 2026, $3.1 billion in Q1 2026, and $3.1 billion in Q4 2025.